???????????????????? ?????????????????? ???????????????????????? ???? ????????? ????????????? ????????????????

O.??. Voloshchuk

Анотація


???????? ?????????????????? ?????? ?????????????? ??????????????????????? ????? 53 ????????? ??????????????????? ??????????? ???????????????????????????? ????????????? ????????? ????????. ?? ?????????????? ????????? ?????? ???????????????? ??? ??????????????????????? ???????????????? ??????? ????????????? ???????? ???????????, ?? ??????? ??????? ?????????????????????? ?ESCAPE?-??????????????: Enterococcus, Staphylococcus, Klebsiella, Pseudomonas. ?????????? ???????????????????????? ???? ???????????? ????????????????? ????????? ???????????????????? ?? ????????????????? ??????????????? ????????????????? (?????) ?? ????????????????? ???????????????????? ????????????????? (?????). ? ????????????? ????????????????? ???????????????? ?????????????? ??????????????????????- ?? ????????????????-????????? ???????????????????? ????? ????????? ????????????????, ? ??????? ?????????????????????? ?????????????? ??????????????? ??????????????????????? ?? ???????????????????????? ????????????????????????? ???????????? ?11 ?? ?????????? ????????????????????????? ???????????? ?? 1-(?????????????-1-????????????)-3-(2,2,6,6-??????????????????????????????)-2-?????????????? ???????????????????. ????? ????????????? ? 11 ??????????????? ???? S. aureus ????????????????? ???????????? 15,6 ??????/ ???, ? ??????????????? Ps. aeruginosa ?? Kl. pneumoniae ???? ?????????????? ????? ?? ???? ?? ??????, ???? ? ?? ????????????? ??????????????????? ?????????????????? (?????????????????? 62,5 ??????/??? ? 7,8 ??????/???).

??????????? ????????: ??????????????????????????, ????????????????????? ????????????????, ?ESKAPE?-?????????????


Повний текст:

PDF

Посилання


Michael CA, Dominey-Howes D, Labbate M. (2014). The antimicrobial resistance crisis: causes, consequences, and management. Front Public Health, 16 (2), 145.

https://doi.org/10.3389/fpubh.2014.00145

Silver LL. (2011). Challenges of antibacterial discovery. Clin Microbiol Rev., 24(1),71-109.

https://doi.org/10.1128/CMR.00030-10

Pendleton JN, Gorman SP, Gilmore BF. (2013). Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther, 11(3):297-308.

https://doi.org/10.1586/eri.13.12

Demain AL, Sanchez S. (2009). Microbial drug discovery: 80 years of progress J Antibiot (Tokyo), 62(1):5-16.

https://doi.org/10.1038/ja.2008.16

Liu J, Obando D, Liao V, Lifa T, Codd R. (2011). The many faces of the adamantyl group in drug design. Eur J Med Chem, 46(6):1949-63.

https://doi.org/10.1016/j.ejmech.2011.01.047

Kovalov I.E. Biologicheskaya aktivnost adamantansoderzashih veschestv (1994). [Biological activity of adamantan based compounds]. Chim. Pharm. Jorn., 5, 19-27.

Korotkiy Yu.V., Vrinchanu N.O., Dronova M.L., Suvorova Z.S., Smertenko O.A. (2015). Sintez, antibakterialna ta antifungalna aktivnist pohidih 1|4 (1,1,3,3, tetrametylbutyl) fenoxi|3 dialkilamino 2 propanol [Synthesis, antibacterial and antifugul activity of derivatives of]. Pharm.J., 1. 56-62.

https://doi.org/10.32352/0367-3057.1.15.04

Nakaz MOZ Ukrainy ? 167 vid 05.04.2007 ?Pro zatverdzhennia metodychnykh vkazivok shchodo vyznachennia chutlyvosti mikroorhanizmiv do antybakterialnykh preparativ? [Order of MOH of Ukraine ? 167 of 05.04.2007 ?On the approval of guidelines to determine the sensitivity of microorganisms to antibiotics?.]. Kyiv, Ministry of Health of Ukraine, 2007. 63 p. (in Ukrainian).




DOI: https://doi.org/10.31548/bio2017.03.001

Метрики статей

Завантаження метрик ...

Metrics powered by PLOS ALM

Посилання

  • Поки немає зовнішніх посилань.


Bookmark and Share